Related Concepts
Related Feeds
AML: Role of LSD1 by CRISPR (Keystone)
Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.
Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.
Related Papers
Annals of Oncology : Official Journal of the European Society for Medical Oncology
J M HernándezJ F San Miguel
Chinese Medical Sciences Journal = Chung-kuo I Hsüeh K'o Hsüeh Tsa Chih
Hu Guo-yuChen Zhen-zhen
Acta Haematologica
Akimichi Ohsaka, Tomoko Hisa
Oncology Letters
Masahide YamamotoOsamu Miura
British Journal of Haematology
M J MozziconacciM Lafage-Pochitaloff